XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Annual Incentive Plan
Common Stock
Common Stock
A&R Plan
Common Stock
Annual Incentive Plan
Additional Paid-In Capital
Additional Paid-In Capital
Annual Incentive Plan
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, shares (in shares) at Mar. 31, 2023     461,199,962            
Beginning balance at Mar. 31, 2023 $ 713,939   $ 46     $ 2,220,897   $ (620) $ (1,506,384)
Issuance of common stock upon exercise of stock options (in shares)     180,718            
Issuance of common stock upon exercise of stock options 85         85      
Issuance of common stock upon release of restricted stock units under the 23andMe Second Amended and Restated Annual Incentive Plan (in shares)       1,812,802 8,961,053        
Issuance of common stock upon release of restricted stock units under the 23andMe Second Amended and Restated Annual Incentive Plan   $ 18,630     $ 1   $ 18,629    
Net share settlements for stock-based minimum tax withholdings (in shares)     (58,985)            
Net share settlements for stock-based minimum tax withholdings (121)         (121)      
Stock-based compensation expense 47,915         47,915      
Other comprehensive loss (334)             (334)  
Net loss (104,624)               (104,624)
Ending balance, shares (in shares) at Jun. 30, 2023     472,095,550            
Ending balance at Jun. 30, 2023 675,490   $ 47     2,287,405   $ (954) (1,611,008)
Beginning balance, shares (in shares) at Mar. 31, 2024     490,119,393            
Beginning balance at Mar. 31, 2024 $ 188,520   $ 49     2,361,559     (2,173,088)
Issuance of common stock upon exercise of stock options (in shares) 137,776   137,776            
Issuance of common stock upon exercise of stock options $ 58         58      
Issuance of common stock upon release of restricted stock units under the 23andMe Second Amended and Restated Annual Incentive Plan (in shares)       3,696,750 12,144,435        
Issuance of common stock upon release of restricted stock units under the 23andMe Second Amended and Restated Annual Incentive Plan   $ 6,451     $ 2   $ 6,449    
Net share settlements for stock-based minimum tax withholdings (in shares)     (88,301)            
Net share settlements for stock-based minimum tax withholdings (48)         (48)      
Stock-based compensation expense 17,923         17,923      
Other comprehensive loss 0                
Net loss (69,400)               (69,400)
Ending balance, shares (in shares) at Jun. 30, 2024     506,010,053            
Ending balance at Jun. 30, 2024 $ 143,504   $ 51     $ 2,385,941     $ (2,242,488)